Primary hyperparathyroidism (PHPT; parathyroid adenoma)
calcium-bone · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Autonomous PTH overproduction (single adenoma ~85%, hyperplasia, rarely carcinoma) causing hypercalcaemia with inappropriately normal/high PTH. Commonest cause of outpatient hypercalcaemia; often asymptomatic on routine bloods. 'Stones, bones, abdominal groans, psychic moans'. (Acute hypercalcaemic crisis is a separate critical entry.)
Red flags
- Calcium >3.5 mmol/L, confusion, dehydration, arrhythmia — treat as hypercalcaemic crisis (critical pathway)
- Very high calcium + very high PTH + neck mass — consider parathyroid carcinoma
- Acute pancreatitis or renal colic as presenting feature
- Rapid rise in calcium with weight loss (suspect malignancy instead)
Assessment
Differential diagnosis
- Malignancy-associated hypercalcaemia (PTHrP, bony mets — PTH SUPPRESSED)
- Familial hypocalciuric hypercalcaemia (FHH) — low urine calcium, family history, do NOT operate
- Secondary/tertiary hyperparathyroidism (CKD)
- Vitamin D toxicity, granulomatous disease, thiazides, lithium, milk-alkali
- Thyrotoxicosis, immobilisation, adrenal insufficiency
Investigations
- Corrected calcium (raised) + PTH (inappropriately normal or high) — the diagnostic pair
- Phosphate (low/low-normal), magnesium, ALP, U&E/eGFR
- 25-OH vitamin D (correct deficiency — it masks severity and worsens bone disease)
- 24-hour urinary calcium + calcium:creatinine clearance ratio (low ratio <0.01 suggests FHH)
- DEXA bone density (including distal 1/3 radius — cortical loss), renal tract ultrasound/CT for nephrocalcinosis/stones
- Localisation ONLY once surgery planned: sestamibi scan +/- neck ultrasound +/- 4D-CT
Management
- Confirm diagnosis (Ca + PTH); exclude FHH before any surgery (urine calcium, family history)
- Correct vitamin D deficiency cautiously and ensure adequate hydration
- Assess end-organ disease: renal function, stones/nephrocalcinosis, bone density, fragility fractures
- Refer for parathyroidectomy if: symptomatic, Ca >0.25 mmol/L above upper limit, age <50, eGFR <60, nephrolithiasis/nephrocalcinosis, or T-score ≤ -2.5 / fragility fracture
- If not operated: monitor calcium, renal function and DEXA; maintain hydration and normal calcium/vitamin D intake
- Cinacalcet to control calcium when surgery declined/unsuitable or in parathyroid carcinoma
- Address osteoporosis with bisphosphonate/denosumab if surgery not performed
Drugs & doses
IV 0.9% saline rehydration if significantly hypercalcaemic/symptomatic (see hypercalcaemia entry for crisis doses)
Cinacalcet 30 mg PO bd, titrate to calcium (max 90 mg bd) — when surgery not an option or carcinoma
Colecalciferol to replete deficiency (e.g. 800-2000 IU/day maintenance) with calcium monitoring
Alendronate 70 mg PO weekly or denosumab 60 mg SC 6-monthly for associated osteoporosis if not operated [verify local]
Avoid thiazides and lithium (raise calcium); ensure good hydration
Disposition
Outpatient endocrine/endocrine-surgery pathway. Admit for hypercalcaemic crisis, severe symptoms, or acute pancreatitis. Surgery is the only cure.
Complications & pitfalls
- Nephrolithiasis, nephrocalcinosis, CKD
- Osteoporosis / osteitis fibrosa cystica, fragility fractures
- Hypercalcaemic crisis, acute pancreatitis, peptic ulcer
- Post-op hungry bone syndrome (profound hypocalcaemia), recurrent laryngeal nerve injury
Exam pearls
- The diagnosis is clinched by a raised calcium with a non-suppressed PTH — in malignancy PTH is suppressed.
- Always exclude FHH (24-h urine calcium, calcium:creatinine clearance ratio <0.01, family history) — surgery does not help and may harm.
- Correct vitamin D deficiency before judging severity; it unmasks higher PTH/bone turnover.
- Watch for hungry bone syndrome after parathyroidectomy in patients with high bone turnover — replace calcium and vitamin D.
- Measure distal radius on DEXA — PHPT preferentially causes cortical bone loss.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.